Safety of 3'-sialyllactose (3'-SL) sodium salt produced by derivative strains of Escherichia coli BL21 (DE3) as a Novel Food pursuant to Regulation (EU) 2015/2283.
Citation
Turck , D , Bohn , T , Castenmiller , J , De Henauw , S , Hirsch-Ernst , K I , Maciuk , A , Mangelsdorf , I , McArdle , H J , Naska , A , Pelaez , C , Pentieva , K , Siani , A , Thies , F , Tsabouri , S , Vinceti , M , Cubadda , F , Frenzel , T , Heinonen , M , Marchelli , R , Neuhäuser-Berthold , M , Poulsen , M , Prieto Maradona , M , Schlatter , J R , van Loveren , H , Colombo , P , Noriega Fernández , E , Knutsen , H K & EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) 2022 , ' Safety of 3'-sialyllactose (3'-SL) sodium salt produced by derivative strains of Escherichia coli BL21 (DE3) as a Novel Food pursuant to Regulation (EU) 2015/2283. ' , EFSA Journal , vol. 20 , no. 5 , e07331 . https://doi.org/10.2903/j.efsa.2022.7331
Rights
This is an open access article under the terms of the Creative Commons Attribution-NoDerivs License,which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made. https://creativecommons.org/licenses/by-nd/4.0/